mRNA drug Discovery
Our Business
Global leader for “mRNA for health”
・Generate intellectual property (IP) on mRNA therapeutics in-house and in collaboration with companies and academia, and license out drug candidates
・Contract research and development of mRNA vaccines and mRNA therapeutics for domestic and foreign companies
mRNA drug discovery platform of NANO MRNA
Pioneer in mRNA drug discovery
- The only company in Japan with proven expertise
- Multiple promising development candidates
- Value chain encompasses the process from seed to development candidate
Capital and business alliance with AXCELEAD* - Comprehensive range of DDS (Drug Delivery System) selection solutions based on our experience
*AXELEAD: HD company that owns AXELEAD Drug Discovery Partners (ADDP) and ARCALIS, among others.
Business Model
Value chain and license-out models for mRNA drug discovery
Revenue model
